©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 7, 2026; 32(9): 114200
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.114200
Published online Mar 7, 2026. doi: 10.3748/wjg.v32.i9.114200
Figure 1 Flowchart of patient selection.
CRC: Colorectal cancer; CEA: Carcinoembryonic antigen.
- Citation: Du FQ, Liu JL, Mai LD, Han XH, Song WJ, Yang D, Zhang QJ, Zhang R, Liu YL, Tong JX. Perioperative serum carcinoembryonic antigen: Powerful marker for prognostic prediction and adjuvant chemotherapy decision-making in patients with stage II and III colorectal cancer. World J Gastroenterol 2026; 32(9): 114200
- URL: https://www.wjgnet.com/1007-9327/full/v32/i9/114200.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i9.114200